Transient cardiac effects in a child with acute cholinergic syndrome due to rivastigmine poisoning

J Emerg Med. 2014 Jul;47(1):21-5. doi: 10.1016/j.jemermed.2013.11.078. Epub 2014 Feb 8.

Abstract

Background: We report a case of rivastigmine poisoning resulting in a full cholinergic syndrome with nicotinic, muscarinic, and central effects requiring supportive or intensive care in a pediatric patient.

Case report: A 3-year-old girl was admitted to the Emergency Department suspected of having ingested one or two pills of rivastigmine. The child was hyporeactive, with symptoms of altered mental status, sialorrhea, sweating, and diarrhea. Subsequently, she started showing signs of respiratory failure, severe tracheobronchial involvement, and gastric and abdominal distension. An electrocardiogram recorded frequent monomorphic ventricular ectopic beats with bigeminy and trigeminy. Long-term follow-up showed a transient dysrhythmia.

Conclusion: Poisoning with rivastigmine can be a life-threatening condition. Timely identification and appropriate management of the toxic effects of this drug are essential and often life-saving. This is particularly true in cases of cholinergic syndrome subsequent to drug poisoning. Patients with cholinergic syndrome should also be assessed for possible cardiac complications such as dysrhythmias. The main factors predisposing to the development of such complications are autonomic disorder, hypoxemia, acidosis, and electrolyte imbalance.

Keywords: cardiac effect; cholinergic syndrome; poisoning; rivastigmine; toxicity.

Publication types

  • Case Reports

MeSH terms

  • Akathisia, Drug-Induced / etiology*
  • Child, Preschool
  • Cholinesterase Inhibitors / poisoning*
  • Cholinesterases / blood
  • Confusion / chemically induced
  • Diarrhea / chemically induced
  • Female
  • Humans
  • Phenylcarbamates / poisoning*
  • Poisoning / therapy
  • Rivastigmine
  • Sialorrhea / chemically induced
  • Sweating / drug effects
  • Syndrome
  • Tachycardia / chemically induced*

Substances

  • Cholinesterase Inhibitors
  • Phenylcarbamates
  • Cholinesterases
  • Rivastigmine